DROXIA 6335 DROXIA 6335 (Droxia 200 mg)

Generic Name: hydroxyurea

This pill with imprint "DROXIA 6335 DROXIA 6335" is Green, Capsule-shape and has been identified as Droxia 200 mg. It is manufactured by Bristol-Myers Squibb.

Droxia is used in the treatment of chronic myelogenous leukemia; anemia, sickle cell; solid tumors and belongs to the drug class antimetabolites. There is positive evidence of human fetal risk during pregnancy. Droxia 200 mg is not a controlled substance under the Controlled Substance Act (CSA).

Droxia

Generic Name:

hydroxyurea

Imprint:

DROXIA 6335 DROXIA 6335

Strength:

200 mg

Color:

Green

Size:

16.00 mm

Shape:

Capsule-shape

Availability:

Prescription only

Drug Class:

Antimetabolites

Pregnancy Category:

D - Positive evidence of risk

CSA Schedule:

Not a controlled drug

Manufacturer:

Bristol-Myers Squibb

National Drug Code (NDC):

00003-6335

Inactive Ingredients:

citric acid monohydrate
gelatin
lactose
magnesium stearate
sodium phosphate
titanium dioxide
FD&C Blue No. 1
FD&C Green No. 3

Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.